Published in J Clin Invest on March 15, 2007
Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol (2010) 2.24
The pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog (2011) 2.04
Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol (2013) 2.04
Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun (2008) 1.91
Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov (2013) 1.82
Medical biofilms. Biotechnol Bioeng (2008) 1.70
Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition. J Bacteriol (2011) 1.45
Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen (2010) 1.44
The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci U S A (2008) 1.41
Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A (2009) 1.39
Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation. ISME J (2014) 1.38
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol (2009) 1.36
The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA. J Bacteriol (2010) 1.29
Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. MBio (2013) 1.22
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob Agents Chemother (2009) 1.20
Medical applications and toxicities of gallium compounds. Int J Environ Res Public Health (2010) 1.15
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37. Front Microbiol (2011) 1.14
Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment. Evol Med Public Health (2014) 1.14
Direct visualization of spatial and temporal patterns of antimicrobial action within model oral biofilms. Appl Environ Microbiol (2008) 1.13
Microcolony formation by the opportunistic pathogen Pseudomonas aeruginosa requires pyruvate and pyruvate fermentation. Mol Microbiol (2012) 1.09
Virulence inhibition by zinc in shiga-toxigenic Escherichia coli. Infect Immun (2011) 1.08
A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat Protoc (2010) 1.07
Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob Agents Chemother (2009) 1.03
Pseudomonas aeruginosa biofilms in disease. Microb Ecol (2013) 1.02
In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2012) 1.02
Host-Microbe Protein Interactions during Bacterial Infection. Chem Biol (2015) 1.01
Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 1.00
Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101. PLoS One (2011) 0.99
The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance. J Bacteriol (2012) 0.96
The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J Bacteriol (2013) 0.94
Cystic fibrosis therapeutics: the road ahead. Chest (2013) 0.91
The putative enoyl-coenzyme A hydratase DspI is required for production of the Pseudomonas aeruginosa biofilm dispersion autoinducer cis-2-decenoic acid. J Bacteriol (2013) 0.90
AmrZ modulates Pseudomonas aeruginosa biofilm architecture by directly repressing transcription of the psl operon. J Bacteriol (2013) 0.90
Antimicrobial tolerance of Pseudomonas aeruginosa biofilms is activated during an early developmental stage and requires the two-component hybrid SagS. J Bacteriol (2013) 0.90
PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilms. J Bacteriol (2012) 0.90
In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Antimicrob Agents Chemother (2009) 0.88
Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. PLoS Pathog (2015) 0.88
Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity. Proc Natl Acad Sci U S A (2016) 0.88
Development of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formation. J Control Release (2013) 0.87
The metal dependence of pyoverdine interactions with its outer membrane receptor FpvA. J Bacteriol (2008) 0.87
PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice. Eur J Clin Microbiol Infect Dis (2011) 0.87
Coal fly ash impairs airway antimicrobial peptides and increases bacterial growth. PLoS One (2013) 0.86
The diguanylate cyclase GcbA facilitates Pseudomonas aeruginosa biofilm dispersion by activating BdlA. J Bacteriol (2014) 0.86
Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. MBio (2014) 0.86
Biofilms 2007: broadened horizons and new emphases. J Bacteriol (2007) 0.85
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun (2016) 0.84
Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system. Mol Microbiol (2015) 0.84
Novel strategies to combat bacterial virulence. Curr Opin Crit Care (2008) 0.84
The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ. J Bacteriol (2013) 0.83
The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source. Antimicrob Agents Chemother (2011) 0.83
BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor. Mol Microbiol (2014) 0.82
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. Front Microbiol (2015) 0.82
Efficacy of AiiM, an N-acylhomoserine lactonase, against Pseudomonas aeruginosa in a mouse model of acute pneumonia. Antimicrob Agents Chemother (2013) 0.82
Inhibition and dispersal of Agrobacterium tumefaciens biofilms by a small diffusible Pseudomonas aeruginosa exoproduct(s). Arch Microbiol (2011) 0.82
Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrob Agents Chemother (2013) 0.82
Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. Antimicrob Agents Chemother (2014) 0.81
Elevated levels of the second messenger c-di-GMP contribute to antimicrobial resistance of Pseudomonas aeruginosa. Mol Microbiol (2014) 0.81
Can resistance against quorum-sensing interference be selected? ISME J (2015) 0.81
Differential activation of Staphylococcus aureus heme detoxification machinery by heme analogues. J Bacteriol (2014) 0.81
The prrF-encoded small regulatory RNAs are required for iron homeostasis and virulence of Pseudomonas aeruginosa. Infect Immun (2014) 0.81
Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function. Environ Sci Nano (2014) 0.81
Penetration kinetics of four mouthrinses into Streptococcus mutans biofilms analyzed by direct time-lapse visualization. Clin Oral Investig (2013) 0.79
The capability of Pseudomonas aeruginosa to recruit zinc under conditions of limited metal availability is affected by inactivation of the ZnuABC transporter. Metallomics (2015) 0.79
Unexpected interaction of a siderophore with aluminum and its receptor. J Bacteriol (2008) 0.79
Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes. Antimicrob Agents Chemother (2015) 0.79
Ga3+ as a mechanistic probe in Fe3+ transport: characterization of Ga3+ interaction with FbpA. J Biol Inorg Chem (2008) 0.79
Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria. BMC Microbiol (2014) 0.79
The LapG protein plays a role in Pseudomonas aeruginosa biofilm formation by controlling the presence of the CdrA adhesin on the cell surface. Microbiologyopen (2015) 0.78
Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum. Antimicrob Agents Chemother (2015) 0.78
Syntheses of Siderophore-Drug Conjugates Using a Convergent Thiol-Maleimide System. ACS Med Chem Lett (2012) 0.77
Functional characterization and metal ion specificity of the metal-citrate complex transporter from Streptomyces coelicolor. J Bacteriol (2008) 0.77
Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis. Antimicrob Agents Chemother (2015) 0.76
Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates. Pharmaceuticals (Basel) (2016) 0.76
Identification and characterization of a novel-type ferric siderophore reductase from a gram-positive extremophile. J Biol Chem (2010) 0.76
Regulation of Pseudomonas aeruginosa Virulence by Distinct Iron Sources. Genes (Basel) (2016) 0.76
Gallium-Loaded Dissolvable Microfilm Constructs that Provide Sustained Release of Ga(3+) for Management of Biofilms. Adv Healthc Mater (2015) 0.76
Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. Antimicrob Agents Chemother (2015) 0.76
Do Bacterial "Virulence Factors" Always Increase Virulence? A Meta-Analysis of Pyoverdine Production in Pseudomonas aeruginosa As a Test Case. Front Microbiol (2016) 0.76
Antibacterial properties of poly (octanediol citrate)/gallium-containing bioglass composite scaffolds. J Mater Sci Mater Med (2015) 0.76
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms. Pharmaceutics (2016) 0.75
Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages. PLoS One (2017) 0.75
Manipulating virulence factor availability can have complex consequences for infections. Evol Appl (2016) 0.75
Chemical interference with iron transport systems to suppress bacterial growth of Streptococcus pneumoniae. PLoS One (2014) 0.75
The efficacy of different anti-microbial metals at preventing the formation of, and eradicating bacterial biofilms of pathogenic indicator strains. J Antibiot (Tokyo) (2017) 0.75
Ga@C-dots as an antibacterial agent for the eradication of Pseudomonas aeruginosa. Int J Nanomedicine (2017) 0.75
Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infection. Antimicrob Agents Chemother (2013) 0.75
Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes. Front Cell Infect Microbiol (2017) 0.75
Pre-treatment with EDTA-gallium prevents the formation of biofilms on surfaces. Exp Ther Med (2013) 0.75
Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection. Antimicrob Agents Chemother (2015) 0.75
Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity. J Mater Sci Mater Med (2016) 0.75
Petrobactin Is Exported from Bacillus anthracis by the RND-Type Exporter ApeX. MBio (2017) 0.75
Osteogenic response and osteoprotective effects in vivo of a nanostructured titanium surface with antibacterial properties. J Mater Sci Mater Med (2016) 0.75
The physical boundaries of public goods cooperation between surface-attached bacterial cells. Proc Biol Sci (2017) 0.75
Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol (2017) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J Bacteriol (2003) 8.11
Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol (2004) 5.55
Aminoglycoside antibiotics induce bacterial biofilm formation. Nature (2005) 4.93
A component of innate immunity prevents bacterial biofilm development. Nature (2002) 4.73
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother (2003) 4.59
Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol (2002) 3.57
GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes. Mol Microbiol (2002) 3.38
Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun (2004) 3.28
Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A (2005) 3.26
Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci U S A (2003) 2.82
Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol (2006) 2.72
Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa. Proc Natl Acad Sci U S A (2002) 2.66
Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 2.55
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis (2005) 2.41
Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology (2005) 2.24
Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU. Crit Care Med (2004) 1.79
Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood (1988) 1.78
Mechanisms of therapeutic activity for gallium. Pharmacol Rev (1998) 1.72
Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother (2004) 1.70
A distinct QscR regulon in the Pseudomonas aeruginosa quorum-sensing circuit. J Bacteriol (2006) 1.69
Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol (2005) 1.67
The effect of passage and iron on the virulence of Pseudomonas aeruginosa. J Clin Pathol (1972) 1.67
Diversity of siderophore-mediated iron uptake systems in fluorescent pseudomonads: not only pyoverdines. Environ Microbiol (2002) 1.53
Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother (1990) 1.49
Biofilms, antimicrobial resistance, and airway infection. N Engl J Med (2002) 1.46
Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol (2006) 1.28
Lactoferrin: a multifunctional glycoprotein. APMIS (1999) 1.26
Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis (2004) 1.25
Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology (2003) 1.06
Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med (1987) 1.05
Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice. J Med Microbiol (1995) 1.01
Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol (2003) 0.98
Lactoferrin: its role as a Ga-67-binding protein in polymorphonuclear leukocytes. J Nucl Med (1981) 0.89
Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase. Biochem Pharmacol (1992) 0.86
Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium. Pathobiology (1991) 0.85
Ofloxacin, norfloxacin and ceftazidime increase the production of alginate and promote the formation of biofilm of Pseudomonas aeruginosa in vitro. J Antimicrob Chemother (1995) 0.83
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia. Chemotherapy (2001) 0.82
Modulation of in vitro and in vivo T-cell responses by transferrin-gallium and gallium nitrate. Blood (1996) 0.82
The role of fluoroquinolones in the promotion of alginate synthesis and antibiotic resistance in Pseudomonas aeruginosa. Curr Microbiol (1997) 0.81
Determination of gallium in soil by slurry-sampling graphite-furnace atomic-absorption spectrometry. Anal Bioanal Chem (2002) 0.80
Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol (2003) 7.29
Self-generated diversity produces "insurance effects" in biofilm communities. Proc Natl Acad Sci U S A (2004) 4.54
Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science (2011) 3.66
Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol (2005) 2.59
Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol (2005) 2.40
Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One (2010) 2.27
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A (2012) 2.22
ExsD is a negative regulator of the Pseudomonas aeruginosa type III secretion regulon. Mol Microbiol (2002) 2.18
Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A (2008) 2.00
Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci U S A (2006) 1.93
agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun (2010) 1.77
Fluorescent reporters for Staphylococcus aureus. J Microbiol Methods (2009) 1.65
Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest (2006) 1.54
The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol (2013) 1.47
Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen (2010) 1.44
PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One (2010) 1.44
Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci U S A (2009) 1.39
Single-copy genes define a conserved order between rice and wheat for understanding differences caused by duplication, deletion, and transposition of genes. Funct Integr Genomics (2006) 1.38
A role for type I signal peptidase in Staphylococcus aureus quorum sensing. Mol Microbiol (2007) 1.35
Modulation of lung epithelial functions by Pseudomonas aeruginosa. Trends Microbiol (2005) 1.34
Pseudomonas aeruginosa acquires biofilm-like properties within airway epithelial cells. Infect Immun (2005) 1.30
Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol (2005) 1.26
Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J Biol Chem (2002) 1.24
Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med (2014) 1.19
Mucin-Pseudomonas aeruginosa interactions promote biofilm formation and antibiotic resistance. Mol Microbiol (2006) 1.19
Oxidation of pyocyanin, a cytotoxic product from Pseudomonas aeruginosa, by microperoxidase 11 and hydrogen peroxide. Free Radic Biol Med (2004) 1.14
Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein. J Infect Dis (2004) 1.13
Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J Leukoc Biol (2006) 1.13
The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.10
The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro. Biochemistry (2013) 1.08
A unique regulator controls the activation threshold of quorum-regulated genes in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2010) 1.07
Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2004) 1.07
Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.05
Pseudomonas aeruginosa OxyR is required for full virulence in rodent and insect models of infection and for resistance to human neutrophils. Infect Immun (2005) 1.04
Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.04
First neonatal case of fungaemia due to Pseudozyma aphidis and a global literature review. Mycoses (2013) 1.03
Pyocyanin and its precursor phenazine-1-carboxylic acid increase IL-8 and intercellular adhesion molecule-1 expression in human airway epithelial cells by oxidant-dependent mechanisms. J Immunol (2005) 1.03
Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob Agents Chemother (2009) 1.03
PLUNC: a multifunctional surfactant of the airways. Biochem Soc Trans (2011) 1.01
Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol (2011) 0.99
Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co-expressing HCV core protein and CYP2E1. J Med Virol (2004) 0.99
The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding. Biochemistry (2014) 0.98
Heme transport exhibits polarity in Caco-2 cells: evidence for an active and membrane protein-mediated process. Am J Physiol Gastrointest Liver Physiol (2004) 0.98
Effects of peroxidase substrates on the Amplex red/peroxidase assay: antioxidant properties of anthracyclines. Anal Biochem (2005) 0.97
Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol (2009) 0.96
Hepatitis C core protein inhibits induction of heme oxygenase-1 and sensitizes hepatocytes to cytotoxicity. Cell Biol Toxicol (2007) 0.96
Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase. Exp Parasitol (2002) 0.96
CSF Biomarkers for Alzheimer's Disease Diagnosis. Int J Alzheimers Dis (2010) 0.94
Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med (2012) 0.94
Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen (2012) 0.91
Genetic variation in biofilms and the insurance effects of diversity. Microbiology (2005) 0.90
The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages. Infect Immun (2004) 0.90
Direct oxidation of 2',7'-dichlorodihydrofluorescein by pyocyanin and other redox-active compounds independent of reactive oxygen species production. Free Radic Biol Med (2004) 0.90
Copper egress is induced by PMA in human THP-1 monocytic cell line. Biometals (2009) 0.88
Airway delivery of silica increases susceptibility to mycobacterial infection in mice: potential role of repopulating macrophages. J Immunol (2009) 0.86
Nitric oxide decreases the stability of DMPO spin adducts. Nitric Oxide (2006) 0.85
Inactivation of anthracyclines by serum heme proteins. Chem Res Toxicol (2007) 0.84
Mapping of seed shattering loci provides insights into origin of weedy rice and rice domestication. J Hered (2013) 0.84
Inactivation of anthracyclines by cellular peroxidase. Cancer Res (2005) 0.83
Oxidation of anthracycline anticancer agents by the peroxidase mimic microperoxidase 11 and hydrogen peroxide. Free Radic Biol Med (2003) 0.83
Photosensitized oxidation and inactivation of pyocyanin, a virulence factor of Pseudomonas aeruginosa. Photochem Photobiol (2006) 0.82
Iron acquisition by Mycobacterium tuberculosis residing within myeloid dendritic cells. Microb Pathog (2013) 0.82
Oxidation of anthracyclines by peroxidase metabolites of salicylic Acid. J Pharmacol Exp Ther (2005) 0.82
The peptidoglycan-associated lipoprotein OprL helps protect a Pseudomonas aeruginosa mutant devoid of the transactivator OxyR from hydrogen peroxide-mediated killing during planktonic and biofilm culture. J Bacteriol (2008) 0.82
Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrob Agents Chemother (2013) 0.82
Acetaminophen stimulates the peroxidative metabolism of anthracyclines. Arch Biochem Biophys (2004) 0.81
Molecular interactions of the physiological anti-hypertensive peptide catestatin with the neuronal nicotinic acetylcholine receptor. J Cell Sci (2012) 0.81
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India. Diagn Microbiol Infect Dis (2013) 0.81
Inactivation of the potent Pseudomonas aeruginosa cytotoxin pyocyanin by airway peroxidases and nitrite. Am J Physiol Lung Cell Mol Physiol (2012) 0.80
Role of thiocyanate, bromide and hypobromous acid in hydrogen peroxide-induced apoptosis. Free Radic Res (2004) 0.80
Doxorubicin inhibits oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS) by a lactoperoxidase/H(2)O(2) system by reacting with ABTS-derived radical. Arch Biochem Biophys (2007) 0.79
Molecular interpretation of ACTH-β-endorphin coaggregation: relevance to secretory granule biogenesis. PLoS One (2012) 0.78
Multivalent metal-induced iron acquisition from transferrin and lactoferrin by myeloid cells. J Immunol (2002) 0.78
Does heme oxygenase-1 have a role in Caco-2 cell cycle progression? Exp Biol Med (Maywood) (2003) 0.78
Enantioselective synthesis of coumarin derivatives by PYBOX-DIPH-Zn(II) complex catalyzed Michael reaction. J Org Chem (2012) 0.78
Quenching of singlet oxygen by pyocyanin and related phenazines. Photochem Photobiol (2010) 0.78
Complexation of amyloid fibrils with charged conjugated polymers. Langmuir (2014) 0.78
Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies. Protein Sci (2008) 0.77
Functional genetic variants of the catecholamine-release-inhibitory peptide catestatin in an Indian population: allele-specific effects on metabolic traits. J Biol Chem (2012) 0.77
Peroxidative metabolism of beta2-agonists salbutamol and fenoterol and their analogues. Chem Res Toxicol (2009) 0.77
Hydrogen peroxide-induced apoptosis of HL-60 human leukemia cells is mediated by the oxidants hypochlorous acid and chloramines. Arch Biochem Biophys (2002) 0.77
Gallium-inducible transferrin-independent iron acquisition is a property of many cell types: possible role of alterations in the plasma membrane. J Investig Med (2005) 0.77
Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activity. J Pharmacol Exp Ther (2010) 0.76
Oxidation of thiols and modification of redox-sensitive signaling in human lung epithelial cells exposed to Pseudomonas pyocyanin. J Toxicol Environ Health A (2011) 0.76
Hemin induces active chloride secretion in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol (2005) 0.75
Pre-hospital care of spinal cord injury in a rural Indian setting. Rural Remote Health (2011) 0.75
Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit Mycobacterial species by Targeting Different Aspects of Iron/Heme Metabolism. ACS Infect Dis (2020) 0.75
Enantioselective Michael addition of malonates to 2-enoylpyridine N-oxides catalyzed by chiral bisoxazoline-Zn(II) complex. Org Lett (2011) 0.75
Structural basis for the species-selective binding of N,C-capped dipeptides to the Mycobacterium tuberculosis proteasome. Biochemistry (2016) 0.75